drugset
drugset / Trial / NCT05202899

Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy

NCT05202899 ↗

Phase 4 Unknown 40 enrolled Guangzhou General Hospital of Guangzhou Military Command
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Effect of sugammadex for reversal of rocuronium-induced neuromuscular block on Perioperative Management of awake Craniotomy

Timeline

Start
2020-09-01
Primary completion
2022-02-28
Completion
2022-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified — —

Indications

brain neoplasm